General Announcement::EXCLUSIVE LICENSE AGREEMENT FOR WAFERMINE AND OTHER SUBLINGUAL KETAMINE WAFER PRODUCTS

Issuer & Securities

Issuer/ Manager
IX BIOPHARMA LTD.
Securities
IX BIOPHARMA LTD. - SG1BD9000009 - 42C
Stapled Security
No

Announcement Details

Announcement Title
General Announcement
Date &Time of Broadcast
24-Nov-2021 09:50:48
Status
New
Announcement Sub Title
EXCLUSIVE LICENSE AGREEMENT FOR WAFERMINE AND OTHER SUBLINGUAL KETAMINE WAFER PRODUCTS
Announcement Reference
SG211124OTHR2FDO
Submitted By (Co./ Ind. Name)
Lee Wei Hsiung
Designation
Company Secretary
Description (Please provide a detailed description of the event in the box below)
Please refer to the attachment.

Attachments

Press Release - Wafermine out-licensing.pdf
Total size =540K